Fresenius Kabi USA flies complaint against NATCO Pharma
Natco Pharma intends to defend the matter accordingly
Natco Pharma intends to defend the matter accordingly
The company will respond to the Warning Letter within the stipulated timelines
NATCO temporarily shut down the operations due to cyclone with flooding/water logging of the factory premises
Natco Pharma has reported total income of Rs. 1060.8 crores during the period ended September 30, 2023
NATCO's Pharmacovigilance Department was inspected from October 30, 2023 to November 1, 2023
The company is confident of addressing all the observations within the stipulated time
Strides Pharma Science Limited to acquire 100% in Strides Pharma Services Pvt Ltd.
Panacea Biotec has announced the launch of its new range of high-quality pediatric food & nutritional products
Natco Chlorantraniliprole (CTPR) Process does not infringe FMC's Indian Patent 298645.
Subscribe To Our Newsletter & Stay Updated